Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-06-29

FDA Approved: DESVENLAFAXINE SUCCINATE — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' generic desvenlafaxine succinate in an Original Application (ANDA 204172) for the treatment of major depressive disorder. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desvenlafaxine succinate (Desvenlafaxine succinate)

Snippet

ORIG AP for DESVENLAFAXINE SUCCINATE (DESVENLAFAXINE SUCCINATE)